Taubman Emerging Scholar Johann Gudjonsson, M.D., Ph.D., receives prestigious research grant
Johann Gudjonsson, M.D., Ph.D., a Taubman Emerging Scholar and assistant professor of dermatology at the University of Michigan Medical school, is among 16 physician-scientists nationwide chosen to receive a prestigious research grant from the Doris Duke Charitable Foundation.
Dr. Gudjonsson will receive $486,000 over three years to continue his study of risk factors for psoriasis. The Doris Duke foundation grants align with the mission of the Taubman Institute's Emerging Scholars Program, which aims to encourage junior faculty to pursue research into new thrapies and cures in addition to clinical practice.
The Clinical Scientist Development Award (CSDA) provides funding for physician-scientists in the process of establishing their own research teams and enables them to secure 75 percent of their professional time for clinical research, the foundation said. This year’s awardees are conducting research in diverse areas, including childhood malnutrition, pancreatic cancer and rheumatoid arthritis.
“For the clinical research workforce to remain strong, we must invest in the next generation of researchers,” said Sindy Escobar-Alvarez, program officer for the Medical Research Program.
“Supporting young physician-scientists as they transition to independence is especially important as they must juggle the responsibilities of conducting research with seeing patients.”
Dr. Gudjonsson approaches the study of psoriasis and other inflammatory diseases at the genetic level, but also contributes to other novel research in the field. Click here to read about a recent study evaluating the effect of tonsillectomy on psoriasis patients, and why the surgery might help with disease symptoms.
Two other U-M clinician-scientists, Santhi Ganesh, M.D., and Adam Lauring, M.D., Ph.D., also received the three-year development awards. Click here to read the entire Doris Duke Charitable Foundation press release.
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
Is there a link between tonsils and psoriasis?
Trial tested the effect of tonsillectomy on the skin disease
Taubman Emerging Scholar Dr. Johann Gudjonsson and colleagues found that people who had their tonsils removed showed improvment.
Click here to read the entire story
Fall Visiting Professor Lectures schedule
Distinguished guest speakers include experts in lung, muscle and nerve diseases
Click here for the lineup
Breast cancer clinical trial enrolling patients
Research by Taubman Scholar Dr. Max Wicha into breast cancer stem cells is the basis for a new human clinical trial of the drug Reparixin, which scientists hope will curb the growth of the tumor-fueling cells.